Long COVID, neuropsychiatric disorders, psychotropics, present and future

The Author(s), 2022. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.stm-assoc.org/about-the-industry/coronavirus-2019-ncov/. ;ISSN: 0924-2708 ;EISSN: 1601-5215 ;DOI: 10.1017/neu.2022.6 ;PMID: 35144718

Digital Resources/Online E-Resources